204 related articles for article (PubMed ID: 24454825)
1. Role of receptor activity modifying protein 1 in function of the calcium sensing receptor in the human TT thyroid carcinoma cell line.
Desai AJ; Roberts DJ; Richards GO; Skerry TM
PLoS One; 2014; 9(1):e85237. PubMed ID: 24454825
[TBL] [Abstract][Full Text] [Related]
2. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane.
Bouschet T; Martin S; Henley JM
J Cell Sci; 2005 Oct; 118(Pt 20):4709-20. PubMed ID: 16188935
[TBL] [Abstract][Full Text] [Related]
3. Regulation of calcium sensing receptor trafficking by RAMPs.
Bouschet T; Martin S; Henley JM
Adv Exp Med Biol; 2012; 744():39-48. PubMed ID: 22434106
[TBL] [Abstract][Full Text] [Related]
4. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
5. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
6. Calcium-Sensing Receptor: Trafficking, Endocytosis, Recycling, and Importance of Interacting Proteins.
Ray K
Prog Mol Biol Transl Sci; 2015; 132():127-50. PubMed ID: 26055057
[TBL] [Abstract][Full Text] [Related]
7. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of RAMP1-RAMP3 chimeras.
Qi T; Simms J; Bailey RJ; Wheatley M; Rathbone DL; Hay DL; Poyner DR
Biochemistry; 2010 Jan; 49(3):522-31. PubMed ID: 20017504
[TBL] [Abstract][Full Text] [Related]
9. Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion.
Freichel M; Zink-Lorenz A; Holloschi A; Hafner M; Flockerzi V; Raue F
Endocrinology; 1996 Sep; 137(9):3842-8. PubMed ID: 8756555
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.
Harikumar KG; Simms J; Christopoulos G; Sexton PM; Miller LJ
Biochemistry; 2009 Dec; 48(49):11773-85. PubMed ID: 19886671
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
12. Extracellular calcium alters calcium-sensing receptor network integrating intracellular calcium-signaling and related key pathway.
Gorkhali R; Tian L; Dong B; Bagchi P; Deng X; Pawar S; Duong D; Fang N; Seyfried N; Yang J
Sci Rep; 2021 Oct; 11(1):20576. PubMed ID: 34663830
[TBL] [Abstract][Full Text] [Related]
13. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.
Bomberger JM; Parameswaran N; Hall CS; Aiyar N; Spielman WS
J Biol Chem; 2005 Mar; 280(10):9297-307. PubMed ID: 15613468
[TBL] [Abstract][Full Text] [Related]
14. Strontium is a biased agonist of the calcium-sensing receptor in rat medullary thyroid carcinoma 6-23 cells.
Thomsen AR; Worm J; Jacobsen SE; Stahlhut M; Latta M; Bräuner-Osborne H
J Pharmacol Exp Ther; 2012 Dec; 343(3):638-49. PubMed ID: 22942242
[TBL] [Abstract][Full Text] [Related]
15. Calcium-Sensing Receptor Internalization Is
Mos I; Jacobsen SE; Foster SR; Bräuner-Osborne H
Mol Pharmacol; 2019 Oct; 96(4):463-474. PubMed ID: 31399503
[TBL] [Abstract][Full Text] [Related]
16. Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer.
Ding H; Yusof AM; Kothandaraman S; Saji M; Wang C; Kumar K; Milum K; Carleton M; Pan X; Ringel MD; Tweedle MF; Phay JE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1722-9. PubMed ID: 24030941
[TBL] [Abstract][Full Text] [Related]
17. Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1.
Bomberger JM; Spielman WS; Hall CS; Weinman EJ; Parameswaran N
J Biol Chem; 2005 Jun; 280(25):23926-35. PubMed ID: 15805108
[TBL] [Abstract][Full Text] [Related]
18. RAMP1 and RAMP3 Differentially Control Amylin's Effects on Food Intake, Glucose and Energy Balance in Male and Female Mice.
Coester B; Pence SW; Arrigoni S; Boyle CN; Le Foll C; Lutz TA
Neuroscience; 2020 Nov; 447():74-93. PubMed ID: 31881259
[TBL] [Abstract][Full Text] [Related]
19. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.
Logan M; Anderson PD; Saab ST; Hameed O; Abdulkadir SA
Am J Pathol; 2013 Sep; 183(3):951-63. PubMed ID: 23867798
[TBL] [Abstract][Full Text] [Related]
20. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
